What defines us
At the Swiss MedTech company Geistlich, we envision a future in which patients' tissue and joints are no longer replaced but regenerated. We invest in our own research and development to drive innovation in regenerative medicine forward. In doing so, we place the highest value on scientific evidence and Swiss quality.
Our Goals
Our Values
Trust is at the heart of the Geistlich brand
Our core values are the driving force behind everything we do and motivate us to give our best every day. We are proud that our work and the values associated with it help us to improve the lives of people around the world.
Our Research and Development
Scientifically sound regenerative medicine
Our passion for science is also reflected in our high volume of research and development. Swiss and international experts and specialists are committed to the common goal of advancing regenerative medicine. The spectrum of our own research is broad and ranges from the investigation of new materials to the manufacture and comprehensive analysis of prototypes and process development in order to be able to produce them on a large scale.
Our philosophy at Geistlich includes not only the development of new products, but also the further training of medical professionals. The result? A Geistlich product is used every 14 seconds worldwide.
Our Quality
First-class Swiss quality
We work closely with specialists to incorporate research findings and clinical expertise into the development of our new products. We attach the utmost importance to the quality of our products, whose clinical efficacy has been proven watertight, as underlined by over 2800 scientific publications.
We strive to carefully prove the clinical efficacy of our products before launching them on the market. We are committed to high quality standards to support the regeneration of natural tissue.
ISO-27001 Information security
Geistlich Pharma AG maintains an information security program and has implemented an Information Security Management System (ISMS). As an ISO/IEC 27001:2013 certified company, Geistlich Pharma AG uses the leading standard ISO/IEC 27001:2013 and applies the guidelines and general principles defined in ISO 27002 to implement, maintain and improve a risk-based information security management system.
This also includes data protection, the internal handling of sensitive data and information and ensuring the integrity and availability of our IT systems.
